LifeMD, Inc. (LFMD): M&A transaction — LifeMD sells majority stake in WorkSimpli for $65M enterprise value; receives $22M cash at close

LifeMD, Inc.

Sold 80% of WorkSimpli units to buyer group led by founder/CEO; enterprise value ~$65M.
LifeMD received ~$22M cash at close (91.6% of $24M base price) for its 73.3% pre-sale ownership.
Sellers eligible for up to $28M additional cash if WorkSimpli meets growth/operational targets over 3 years.
LifeMD expects to use NOL carryforwards to offset most capital gains from the sale.
Transaction positions LifeMD as pure-play virtual care and pharmacy; plans cardiometabolic expansion in H1 2026.

item 1.01 item 2.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

LifeMD, Inc. completed a disposition involving Lion Buyer, LLC for up to $52.0 million (closed 2025-11-04).

Action: disposition
Counterparty: Lion Buyer, LLC
Consideration: up to $52.0 million
Closing: 2025-11-04

Exact text from the filing

aggregate purchase price paid at close and 53.8% ($28.0 million) subject to future performance targets, for an aggregate purchase consideration paid to the Sellers of up to $52.0 million: ● 46.2% of the aggregate purchase price consists of a cash payment equal to the base purchase price of $24.0 million, subject to adjustments for net working capital, cash,

View on SEC.gov

Browse all m&a transactions →

LifeMD, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-020713

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.